Cargando…
Glutamatergic Mechanisms in Glioblastoma and Tumor-Associated Epilepsy
The progression of glioblastomas is associated with a variety of neurological impairments, such as tumor-related epileptic seizures. Seizures are not only a common comorbidity of glioblastoma but often an initial clinical symptom of this cancer entity. Both, glioblastoma and tumor-associated epileps...
Autores principales: | Lange, Falko, Hörnschemeyer, Julia, Kirschstein, Timo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156732/ https://www.ncbi.nlm.nih.gov/pubmed/34067762 http://dx.doi.org/10.3390/cells10051226 |
Ejemplares similares
-
Studies on Biological and Molecular Effects of Small-Molecule Kinase Inhibitors on Human Glioblastoma Cells and Organotypic Brain Slices
por: Hörnschemeyer, Julia, et al.
Publicado: (2022) -
AMPA receptor antagonist perampanel affects glioblastoma cell growth and glutamate release in vitro
por: Lange, Falko, et al.
Publicado: (2019) -
Galvanotactic Migration of Glioblastoma and Brain Metastases Cells
por: Lange, Falko, et al.
Publicado: (2022) -
Perampanel Add-on to Standard Radiochemotherapy in vivo Promotes Neuroprotection in a Rodent F98 Glioma Model
por: Lange, Falko, et al.
Publicado: (2020) -
Oxytocin and Addiction: Potential Glutamatergic Mechanisms
por: Sundar, Megana, et al.
Publicado: (2021)